Halifax Group Welcomes Howard Miller as Operating Executive
Halifax Group, a prominent private equity firm, is excited to announce the appointment of Howard C. Miller as their newest Operating Executive. With extensive experience in healthcare and life sciences, Mr. Miller will significantly contribute to Halifax's investment and strategic efforts in the healthcare sector.
Expertise in Pharmaceutical Services
Mr. Miller has over 30 years of experience, having formerly held the position of CEO at Envision Pharma Group, where he led the firm in providing technology-enabled strategic solutions in the life sciences realm. He brings invaluable insights from his tenure at Two Labs Pharma Consulting, where he served as a Founding Partner and CEO, helping guide the company through its notable growth period before its acquisition. His impressive career also includes vital roles at Cardinal Health and Abbott Laboratories, demonstrating his robust background in sales and marketing.
Vision for Growth and Mentorship
Scott Plumridge, the Managing Partner at Halifax, expressed enthusiasm about Mr. Miller's addition to the team. "Meeting Howard nearly a decade ago was a turning point for us; his expertise and leadership in high-growth businesses have always impressed us. We are eager to integrate his extensive experience into our operations and look forward to the positive impact he will have on our organization."
Commitment to People-First Philosophy
Sharing a core belief in fostering a people-first culture, Mr. Miller articulated his excitement to join Halifax. He noted, "I am eager to collaborate with the Halifax team, united in our commitment to enhance employee engagement and patient care. This guiding principle is crucial as we work to discover new avenues for growth and success within the Halifax portfolio of companies."
About Halifax Group
Halifax Group, founded in 1999, specializes in private equity investments, focusing on lower middle-market companies. With total enterprise values typically ranging from $100 million to $300 million, Halifax partners with managers to recapitalize businesses and strives to create value through equity recapitalizations, corporate carve-outs, and management buyouts. Their investment sectors include health and wellness, outsourced business services, and franchising. Headquartered in Washington, D.C., Halifax also operates an office in Raleigh, NC.
Contact Information
For more inquiries, please reach out to Caroline Luz at Lambert by LLYC at 203-570-6462. We welcome discussions about potential investment opportunities and partnerships.
Frequently Asked Questions
What role will Howard Miller play at Halifax Group?
Howard Miller will serve as Operating Executive, focusing on evaluating healthcare sector investment opportunities and mentoring executive teams.
What experience does Howard Miller bring to Halifax?
Miller has over 30 years of experience in healthcare and life sciences, having led Envision Pharma Group and served as CEO at Two Labs Pharma Consulting.
What is Halifax Group's focus in their investments?
Halifax Group focuses on lower middle-market businesses, specializing in equity recapitalizations and management buyouts across various sectors, including health and wellness.
Where is Halifax Group headquartered?
Halifax Group is headquartered in Washington, D.C., with an additional office in Raleigh, NC.
How can I contact Halifax Group for investment opportunities?
Interested parties can contact Caroline Luz at Lambert by LLYC to discuss potential investment opportunities.
